Insider Trading activities of Stemcells Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Stemcells Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Stemcells Inc since year 2005. Table 2 shows the detailed insider transactions of Stemcells Inc since 2005. The reporting company's ticker symbol is MBOT. The reporting company's CIK number is 883975.
The total value of stock buying since 2005 is $25,900.
The total value of stock sales since 2005 is $2,460,778.
The total value of stock option exercises since 2005 is $1,316,667.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Stemcells Inc (MBOT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 158,700 $215,776 0 $0
2017-09 0 $0 415,610 $511,028 0 $0
2017-08 0 $0 35,000 $37,175 0 $0
2017-06 0 $0 71,224 $118,944 0 $0
2015-12 0 $0 104,549 $47,151 0 $0
2011-05 0 $0 49,100 $33,388 0 $0
2010-05 0 $0 8,801 $9,329 0 $0
2010-03 0 $0 75,533 $91,994 0 $0
2009-11 0 $0 3,647 $3,975 0 $0
2009-08 0 $0 0 $0 50,000 $70,200
2009-05 0 $0 10,000 $17,000 10,000 $6,100
2009-04 0 $0 561,036 $947,918 155,164 $81,721
2008-06 0 $0 127,700 $161,144 47,700 $61,103
2008-04 0 $0 80,000 $110,981 0 $0
2007-12 0 $0 100,000 $154,975 0 $0
2007-03 10,000 $25,900 0 $0 0 $0
2007-01 0 $0 0 $0 292,000 $648,240
2006-10 0 $0 0 $0 194,000 $449,303

Table 2. Detailed insider stock purchases, sales, and option exercises of Stemcells Inc insiders (MBOT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-10 Bornstein Yoseph Sale 50,000 1.38 68,900
2017-10-09 Shoham Moshe Sale 16,600 1.50 24,900
2017-10-05 Shoham Moshe Sale 17,100 1.50 25,684
2017-10-05 Bornstein Yoseph Sale 22,000 1.49 32,802
2017-10-04 Bornstein Yoseph Sale 3,000 1.48 4,440
2017-10-03 Bornstein Yoseph Sale 50,000 1.18 59,050
2017-09-26 Bornstein Yoseph Sale 50,000 1.24 61,900
2017-09-19 Bornstein Yoseph Sale 50,000 1.19 59,250
2017-09-15 Shoham Moshe Sale 250,000 1.28 320,500
2017-09-12 Bornstein Yoseph Sale 20,000 1.12 22,400
2017-09-06 Bornstein Yoseph Sale 45,610 1.03 46,978
2017-08-30 Bornstein Yoseph Sale 10,000 1.06 10,650
2017-08-25 Bornstein Yoseph Sale 15,000 1.08 16,215
2017-08-24 Bornstein Yoseph Sale 10,000 1.03 10,310
2017-06-16 Lewkowicz Leon Sale 71,224 1.67 118,944
2015-12-29 Stratton Kenneth Blair (General Counsel) Sale 104,549 .45 47,151
2011-05-20 Tsukamoto Ann (EVP, Research and Development) Sale 49,100 .68 33,388
2010-05-18 Koshy George (Other) Sale 8,801 1.06 9,329
2010-03-17 Young Rodney Kb (CFO) Sale 30,000 1.23 36,900
2010-03-16 Stratton Kenneth Blair (General Counsel) Sale 29,683 1.21 35,916
2010-03-16 Koshy George (Other) Sale 15,850 1.21 19,178
2009-11-20 Young Rodney Kb (CFO) Sale 3,647 1.09 3,975
2009-08-17 Tsukamoto Ann (EVP, Research and Development) Option Ex 50,000 1.40 70,200
2009-05-12 Koshy George (Other) Sale 10,000 1.70 17,000
2009-05-12 Koshy George (Other) Option Ex 10,000 .61 6,100
2009-04-16 Weissman Irving (Director) Sale 50,000 1.70 85,000
2009-04-07 Koshy George (Other) Sale 10,000 1.61 16,100
2009-04-07 Koshy George (Other) Option Ex 10,000 .61 6,100
2009-04-03 Stratton Kenneth Blair (General Counsel) Sale 17,018 1.65 28,147
2009-04-03 Mcglynn Martin M (President & CEO) Sale 145,344 1.66 241,416
2009-04-03 Mcglynn Martin M (President & CEO) Option Ex 57,000 .94 53,580
2009-04-02 Young Rodney Kb (CFO) Sale 47,092 1.70 79,962
2009-04-02 Koshy George (Other) Sale 16,602 1.73 28,721
2009-04-02 Tsukamoto Ann (EVP, Research and Development) Sale 36,816 1.72 63,286
2009-04-02 Weissman Irving (Director) Sale 150,000 1.72 257,700
2009-04-02 Schwartz John J (Director) Sale 88,164 1.67 147,586
2009-04-02 Schwartz John J (Director) Option Ex 88,164 .25 22,041
2008-06-30 Weissman Irving (Director) Sale 60,000 1.19 71,100
2008-06-27 Weissman Irving (Director) Sale 20,000 1.23 24,580
2008-06-17 Schwartz John J (Director) Sale 24,600 1.37 33,702
2008-06-17 Schwartz John J (Director) Option Ex 24,600 1.28 31,512
2008-06-16 Schwartz John J (Director) Sale 23,100 1.38 31,762
2008-06-16 Schwartz John J (Director) Option Ex 23,100 1.28 29,591
2008-04-28 Weissman Irving (Director) Sale 7,346 1.39 10,210
2008-04-18 Weissman Irving (Director) Sale 72,654 1.39 100,771
2007-12-21 Weissman Irving (Director) Sale 75,000 1.54 115,350
2007-12-20 Weissman Irving (Director) Sale 25,000 1.58 39,625
2007-03-07 Oconnell Desmond H Jr (Director) Buy 9,000 2.61 23,472
2007-03-06 Oconnell Desmond H Jr (Director) Buy 1,000 2.43 2,428
2007-01-08 Mcglynn Martin M (President & CEO) Option Ex 292,000 2.22 648,240
2006-10-27 Mcglynn Martin M (President & CEO) Option Ex 194,000 2.32 449,303

Insider trading activities including stock purchases, stock sales, and option exercises of MBOT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Stemcells Inc (symbol MBOT, CIK number 883975) see the Securities and Exchange Commission (SEC) website.